Viewing Study NCT00805233


Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2026-01-09 @ 9:50 PM
Study NCT ID: NCT00805233
Status: COMPLETED
Last Update Posted: 2011-07-22
First Post: 2008-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration
Sponsor: Oregon Health and Science University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: FVF4442
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Peter J. Francis, MD, PhD
Old Organization: Oregon Health & Science University

Collaborators

Collaborators

Name Class View
None INDUSTRY View